Marco Philippe H 4
4 · XTENT INC · Filed Feb 5, 2008
Insider Transaction Report
Form 4
XTENT INCXTNT
Marco Philippe H
VP Quality Assurance, Clinical
Transactions
- Sale
Common Stock
2008-02-01$9.75/sh−400$3,900→ 100,050 total - Sale
Common Stock
2008-02-01$9.42/sh−300$2,826→ 102,450 total - Sale
Common Stock
2008-02-01$9.65/sh−500$4,825→ 101,450 total - Sale
Common Stock
2008-02-01$9.41/sh−200$1,882→ 102,750 total - Sale
Common Stock
2008-02-01$9.39/sh−100$939→ 102,950 total
Footnotes (1)
- [F1]Sale pursuant to rule 10b5-1(c) under the Securities and Exchange Act of 1934, as amended